Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| foaf:name |
|
| foaf:homepage | |
| founding date |
|
| founding year |
|
| industry | |
| key person | |
| location | |
| number of employees |
|
| product | |
| type |